Management of Diabetes Complications During and After COVID-19

View Sample PDF

Author(s): Mubeen Fatima (University of the Punjab, Pakistan), Safdar Hussain (University of the Punjab, Pakistan), Momal Babar (University of the Punjab, Pakistan), Nosheen Mushtaq (Riphah International University, Lahore, Pakistan)and Tehseen Fatima (Government College University, Lahore, Pakistan)
Copyright: 2024
Pages: 26
Source title: Clinical Practice and Post-Infection Care for COVID-19 Patients
Source Author(s)/Editor(s): Gunda Varaprasad Rao (NMH Heart Care Center, Nashik, India)and Sangeeta Dhamdhere-Rao (Modern College of Arts, Science, and Commerce, Pune, India)
DOI: 10.4018/978-1-6684-6855-5.ch005

Keywords: Cardiovascular Medicine / Medical Diagnosis and Practice / Medical Information Science Reference / Medicine & Healthcare

Purchase

View Management of Diabetes Complications During and After COVID-19 on the publisher's website for pricing and purchasing information.

Abstract

At least 200 million people were affected by the corona virus (COVID-19) disease during the pandemic, and over 5 million deaths occurred by October 2021. In 2021, the International Diabetes Federation (IDF) reported that 537 million people worldwide were living with diabetes, and it caused 6.7 million deaths. Long-term COVID-19 patients endure a broad variety of physical and mental problems. People with long-term COVID-19 generally report low living quality, poor mental health, and unemployment on top of their suffering and problems. These patients may need long-term symptoms monitoring, social assistance, physical rehabilitation, and management of diabetes complications. Future health issues related to long COVID-19 and diabetes will need resilient healthcare systems to enable fast and effective solutions.

The IRMA Community

Research IRM

Management of Diabetes Complications During and After COVID-19

Purchase

Abstract

Related Content

IRMA Sponsors